cdmo.directory
← Compare landing

Grifols Partnership vs Siegfried Holding

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/grifols/siegfried

CategoryGrifols PartnershipSiegfried Holding
Listed sitecdmocdmo
SummaryCDMO specializing in small molecule injectable products, including concentrated and diluted parenteral formulations and intravenous solutions, leveraging 100+ years of Grifols expertise.Global CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.
Services
  • Formulation Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • API Synthesis & Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Process Development
  • Small Molecule Development & Manufacturing
  • Quality Control Testing
  • CMC Analytical Development
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Controlled Substance Manufacturing
  • Flow Chemistry & Continuous Manufacturing
  • Oral Solid Dosage Manufacturing
  • Vial Filling
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Ophthalmic Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Cold-Chain Storage & Logistics
  • Viral Vector Manufacturing
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
  • Technology Transfer
  • Formulation Development
  • CMC Regulatory Submission Support
Modalities
  • Biologics (Other)
  • Small Molecule
  • Gene Therapy
  • Small Molecule
Indications
  • Immunology
  • Neurology
  • Cardiovascular
  • Infectious Disease
  • Respiratory
Data not yet provided.
Locations
  • Headquarters, Sant Cugat del Vallès, Catalonia, Spain
  • Headquarters, Zofingen, Aargau, Switzerland
  • Drug Substances & R&D, Evionnaz, Valais, Switzerland
  • Viral Vector Manufacturing, Schlieren, Zurich, Switzerland
  • Drug Products, Hameln, Lower Saxony, Germany
  • Drug Substances, Minden, North Rhine-Westphalia, Germany
  • Drug Substances, St. Vulbas, Auvergne-Rhône-Alpes, France
CertificationsData not yet provided.
  • FDA · Identifier: U.S. Food and Drug Administration
  • Swissmedic · Identifier: Swissmedic
  • PMDA · Identifier: Japan's Pharmaceuticals and Medical Devices Agency
  • AEMPS · Identifier: Spanish Agency of Medicines and Medical Devices
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.